AI aims to improve colon polyp measurement for cancer prevention

NCT ID NCT06957015

Recruiting now Diagnosis Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an AI tool called EndoAIM that helps doctors measure the size of polyps found during a colonoscopy. Accurate size measurement is important because larger polyps (over 10 mm) have a higher risk of becoming cancer. The study will enroll 278 adults undergoing colonoscopy to see if the AI improves measurement accuracy compared to standard methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: EndoAIM (AI software device used during colonoscopy)
What this could lead to: If successful, this AI tool could help doctors more accurately measure polyp size, leading to better decisions about cancer risk and follow-up care.
What could go wrong: This is an early-stage study with 278 participants, so results may not apply to all patients. The AI may not perform better than current methods, and technical issues could affect accuracy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE (AI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal carcinoma colorectal neoplasm polyp of colon

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTIFICIAL INTELLIGENCE (AI) COLONIC POLYPS CRC (COLORECTAL CANCER)

Contacts and locations

Locations

Prince of Wales Hospital
RECRUITING

Shatin, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.